Geneos Therapeutics Company

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Industry: DNA
Headquarters: Plymouth Meeting, Pennsylvania, United States
Founded Date: 2016-08-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 5
Total Funding: 39500000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-03-24
Last Funding Type: Series A

Visit Website
Register and Claim Ownership